SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-021423
Filing Date
2019-08-08
Accepted
2019-08-08 21:24:22
Documents
2
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3934
2 EX-24 DOCUMENT attachment1.htm EX-24 5145
  Complete submission text file 0000899243-19-021423.txt   10622
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address
Royston Aaron (Reporting) CIK: 0001727703 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38356 | Film No.: 191011135